References
- Writing Group for the Women's Health Initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Prin-cipal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2003;288:321–33
- Million Women's Study collaborators. Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 2003;362:419–27
- Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. J Am Med Assoc 2004;291:47–53
- Grodstein F, Stampfer MJ, Manson JE, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335: 453–61
- Shapiro S. The Million Women Study: potential biases do not allow uncritical acceptance of the data. Climacteric 2004;7:3–7
- Shapiro S. Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial. Climacteric 2003;6:302–10